Midday stocks: Biohaven plunges 16% as AI, homebuilding shares retreat
AI Summary- Biohaven fell 16% after the FDA imposed a partial clinical hold on an epilepsy treatment.
- AeroVironment reported adjusted earnings of 59 cents per share and $480 million in revenue.
- Enbridge announced a $2.55 billion acquisition of Tallgrass Energy’s crude transportation business.